Cleared Traditional

K181334 - ADVIA Centaur Herpes-2 IgG

K181334 is an FDA 510(k) clearance for ADVIA Centaur Herpes-2 IgG, manufactured by Biokit, S.A.. The device is a Class 2 Microbiology device with product code MYF cleared through the Traditional 510(k) pathway after a 94-day FDA review.

K181334 · Biokit, S.A. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
94d
Days
Class 2
Risk

K181334 is an FDA 510(k) clearance for the ADVIA Centaur Herpes-2 IgG. Classified as Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2 (product code MYF), Class II - Special Controls.

Submitted by Biokit, S.A. (Lliça D'Amunt, ES). The FDA issued a Cleared decision on August 23, 2018 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3305 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Biokit, S.A. devices

FDA 510(k) Submission Details - K181334

510(k) Number K181334 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 21, 2018
Decision Date August 23, 2018
Days to Decision 94 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 102d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MYF Device Classification - Class 2, Special Controls

Product Code MYF Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3305
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - MYF Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2

All 7
Devices cleared under the same product code (MYF) and FDA review panel - the closest regulatory comparables to K181334.
ARCHITECT HSV-2 IgG, ARCHITECT HSV-2 IgG Calibrator, ARCHITECT HSV-2 IgG Controls
K243575 · Biokit, S.A. · Feb 2025
Elecsys HSV-2 IgG (08948887160)
K220924 · Roche Diagnostics · Oct 2022
SeraQuest HSV Type 2 Specific IgG
K181514 · Quest International, Inc. · Jun 2019
SeraQuest HSV Type 2 Specific IgG
K152353 · Quest International, Inc. · May 2016
ZEUS ELISA HSV GG-2 IGG TEST SYSTEM
K103603 · Zeus Scientific, Inc. · May 2011
LIAISON HSV-2 TYPE SPECIFIC IGG ASSAY, CONTROL HSV-2 IGG
K081687 · DiaSorin, Inc. · Nov 2008